Annovis Bio
ANVS
ANVS
35 hedge funds and large institutions have $9.5M invested in Annovis Bio in 2024 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.22% more ownership
Funds ownership: 8.81% → 9.03% (+0.22%)
72% less call options, than puts
Call options by funds: $3.33M | Put options by funds: $12M
Holders
35
Holding in Top 10
–
Calls
$3.33M
Puts
$12M
Top Buyers
| 1 | +$828K | |
| 2 | +$425K | |
| 3 | +$371K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$254K |
| 5 |
D.E. Shaw & Co
New York
|
+$197K |
Top Sellers
| 1 | -$576K | |
| 2 | -$176K | |
| 3 | -$115K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$89.8K |
| 5 |
Morgan Stanley
New York
|
-$33.4K |